Javascript must be enabled to continue!
ADVANCEMENTS IN THERAPEUTICS: THE ROLE OF NANOPARTICLE-INFUSED HYDROGELS IN REVOLUTIONIZING DRUG DELIVERY
View through CrossRef
Nanoparticles loaded hydrogel has emerged as a promising strategy in the field of drug delivery systems, offering unique advantages in terms of controlled release, enhanced bioavailability, and targeted delivery of therapeutic agents. Nanoparticles, typically ranging from 1 to 100 nanometers in size, serve as carriers for drugs, encapsulating them within their matrix and protecting them from degradation. Hydrogels, on the other hand, are three-dimensional cross-linked networks of hydrophilic polymers capable of absorbing and retaining large amounts of water. It aims to provide a comprehensive understanding of nanoparticles loaded hydrogel in drug delivery systems by elucidating the relationship between nanoparticles and hydrogels and their synergistic effects on drug delivery. Firstly, the properties of nanoparticles, including size, surface charge, and composition, significantly influence their interactions with hydrogels and the encapsulation efficiency of drugs. Secondly, the unique characteristics of hydrogels, such as tunable swelling behavior and biocompatibility, complement the stability and sustained release kinetics of nanoparticles.Furthermore, the incorporation of nanoparticles into hydrogel matrices enhances their mechanical strength and allows for the development of stimuli-responsive systems, enabling on-demand drug release triggered by external stimuli such as pH, temperature, or magnetic fields. The synergistic combination of nanoparticles and hydrogels opens up new avenues for the design of advanced drug delivery systems with improved therapeutic efficacy and reduced side effects. In conclusion, nanoparticles loaded hydrogel represents a promising platform for the development of next-generation drug delivery systems, offering unprecedented control over drug release kinetics and targeting capabilities. This review highlights the importance of understanding the interplay between nanoparticles and hydrogels in optimizing the performance of drug delivery systems for various biomedical applications.
International Journal Of Advanced Research
Title: ADVANCEMENTS IN THERAPEUTICS: THE ROLE OF NANOPARTICLE-INFUSED HYDROGELS IN REVOLUTIONIZING DRUG DELIVERY
Description:
Nanoparticles loaded hydrogel has emerged as a promising strategy in the field of drug delivery systems, offering unique advantages in terms of controlled release, enhanced bioavailability, and targeted delivery of therapeutic agents.
Nanoparticles, typically ranging from 1 to 100 nanometers in size, serve as carriers for drugs, encapsulating them within their matrix and protecting them from degradation.
Hydrogels, on the other hand, are three-dimensional cross-linked networks of hydrophilic polymers capable of absorbing and retaining large amounts of water.
It aims to provide a comprehensive understanding of nanoparticles loaded hydrogel in drug delivery systems by elucidating the relationship between nanoparticles and hydrogels and their synergistic effects on drug delivery.
Firstly, the properties of nanoparticles, including size, surface charge, and composition, significantly influence their interactions with hydrogels and the encapsulation efficiency of drugs.
Secondly, the unique characteristics of hydrogels, such as tunable swelling behavior and biocompatibility, complement the stability and sustained release kinetics of nanoparticles.
Furthermore, the incorporation of nanoparticles into hydrogel matrices enhances their mechanical strength and allows for the development of stimuli-responsive systems, enabling on-demand drug release triggered by external stimuli such as pH, temperature, or magnetic fields.
The synergistic combination of nanoparticles and hydrogels opens up new avenues for the design of advanced drug delivery systems with improved therapeutic efficacy and reduced side effects.
In conclusion, nanoparticles loaded hydrogel represents a promising platform for the development of next-generation drug delivery systems, offering unprecedented control over drug release kinetics and targeting capabilities.
This review highlights the importance of understanding the interplay between nanoparticles and hydrogels in optimizing the performance of drug delivery systems for various biomedical applications.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
AI-infused patients for enhanced clinical simulation
AI-infused patients for enhanced clinical simulation
Artificial intelligence (AI) refers to the simulation of human intelligence in computers, allowing them to perform tasks that usually require human cognitive abilities, such as dec...
Comparative Study of the Mechanical Properties of New PEGSSDA Hydrogels, and Their Effect on Embedded Stem Cell Secretome
Comparative Study of the Mechanical Properties of New PEGSSDA Hydrogels, and Their Effect on Embedded Stem Cell Secretome
Hydrogels are hyaluronic acid and collagen‐based polymer networks that mimic the 3D cell microenvironment and can be used as tissue‐engineered scaffolds for therapeutic delivery of...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...

